第一单位：
Wilmot Cancer Institute, University of Rochester, Rochester, NY, USA.
作者：
Jonathan W,Friedberg [1]
;
Michael T,Brady [1]
;
Myla,Strawderman [2]
;
Brad S,Kahl [3]
;
Izidore S,Lossos [4]
;
Jonathon B,Cohen [5]
;
Patrick M,Reagan [1]
;
Carla,Casulo [1]
;
Barbara L,Averill [6]
;
Andrea,Baran [2]
;
Grerk,Sutamtewagul [7]
;
Paul M,Barr [1]
;
John P,Leonard [8]
;
John M,Ashton [9]
;
John G,Strang [10]
;
Francisco,Vega [11]
;
Derick R,Peterson [12]
;
Loretta J,Nastoupil [6]
作者单位：
Wilmot Cancer Institute, University of Rochester, Rochester, NY, USA.
[1]
Department of Biostatistics and Computational Biology, University of Rochester, Rochester, NY, USA.
[2]
Siteman Cancer Center, Washington University School of Medicine in St. Louis, St. Louis, MO, USA.
[3]
Sylvester Comprehensive Cancer Center, Division of Hematology, University of Miami Miller School of Medicine, Miami, FL, USA.
[4]
Winship Cancer Institute, Department of Hematology and Medical Oncology, Emory University School of Medicine, Atlanta, GA, USA.
[5]
Department of Lymphoma and Myeloma, MD Anderson Cancer Center, Houston, TX, USA.
[6]
Division of Hematology, Oncology and Blood & Marrow Transplantation, University of Iowa Hospitals and Clinics, Iowa City, IA, USA.
[7]
Weill Medical College of Cornell University and New York Presbyterian Hospital, New York, NY, USA.
[8]
Wilmot Cancer Institute, University of Rochester, Rochester, NY, USA.;Department of Biomedical Genetics, University of Rochester, Rochester, NY, USA.
[9]
Department of Imaging Sciences, University of Rochester, Rochester, NY, USA.
[10]
Department of Hematopathology, MD Anderson Cancer Center, Houston, TX, USA.
[11]
Wilmot Cancer Institute, University of Rochester, Rochester, NY, USA.;Department of Biostatistics and Computational Biology, University of Rochester, Rochester, NY, USA.
[12]
DOI
10.1016/j.eclinm.2024.102959
PMID
39677358
发布时间
2025-01-04
换一批
